Skip to main content

Table 11 Association of QRS duration changes with the cTnI changes six months after the completion of anthracycline chemotherapy

From: Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka

 

cTnI < 0.04 ng/mL

cTnI ≥ 0.04 ng/mL

QRS duration ≤ 120 ms

100 (64.9%)

54 (35.1%)

QRS duration > 120 ms

15 (35.7%)

27 (64.3%)

  1. n = 196, p-value = 0.001**
  2. cTnI cardiac troponin I
  3. p values *< 0.05, **< 0.01, ***< 0.001 considered as significant